KLRC2 and plasma cell myeloma: Correlation of seropositivity for CMV with increased expression of activating receptor NKG2C has previously been described [40], with NKG2C+ impacting cytotoxicity on HLA-E expressing cells such as haematological malignancies which have been shown to affect myeloma cells [41].